Bioprocess development of antibody-drug conjugate production for cancer treatment
PDF) Linkers Having a Crucial Role in Antibody–Drug Conjugates
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
ADC Pharmacokinetics Characterization - Creative Biolabs
Antibody–Drug Conjugates: Perspectives and Characterization | Chromatography Online
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports
Anti-Cancer ADC Drugs: 3 Design Elements, 10 Approved ADCs, Multiple Clinical Trials | Biochempeg
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
Conjugation methods for ADC development. ADC production using... | Download Scientific Diagram
Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.,Analytical Chemistry - X-MOL
Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports
BTG-driven conjugation: Antibodies for medicine
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Antibody-drug conjugate - Wikipedia
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin | Scientific Reports
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
ANTIBODY DRUG CONJUGATES - ADC Development Using SMARTag(TM) Technology
